Dan Qiu , Eleni Friligkou , Jun He , Brenda Cabrera-Mendoza , Mihaela Aslan , Mihir Gupta , Renato Polimanti
{"title":"利用观察性和遗传学分析了解精神疾病、慢性腰痛和脊柱退行性疾病的合并症","authors":"Dan Qiu , Eleni Friligkou , Jun He , Brenda Cabrera-Mendoza , Mihaela Aslan , Mihir Gupta , Renato Polimanti","doi":"10.1016/j.bpsgos.2025.100588","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Psychiatric disorders and symptoms are associated with differences in pain perception and sensitivity. These differences can have important implications in treating spinal degenerative disease (SDD) and chronic low back pain (CLBP).</div></div><div><h3>Methods</h3><div>Leveraging UK Biobank (UKB) (<em>n</em> = 402,072) and All of Us Research Program (AoU) (<em>n</em> = 157,415) data, we investigated the effects linking psychiatric disorders to SDD and CLBP. We applied multinominal regression models, polygenic risk scoring, and one-sample Mendelian randomization (MR) to triangulate the effects underlying the observed associations. We also performed gene ontology and drug-repurposing analyses to dissect the biology shared among mental illnesses, SDD, and CLBP.</div></div><div><h3>Results</h3><div>When we compared individuals affected only by SDD, those affected only by CLBP, and those affected by both conditions with control participants, observational and genetically informed analyses highlighted that the strongest effects across the 3 case groups were observed for alcohol use disorder, anxiety, depression, and posttraumatic stress disorder. Additionally, schizophrenia and its polygenic risk score appeared to have an inverse relationship with CLBP, SDD, and their comorbidity. One-sample MR highlighted a potential direct effect of internalizing disorders on the outcomes investigated that was particularly strong on SDD. Our drug repurposing analyses identified histone deacetylase inhibitors as targeting molecular pathways shared by psychiatric disorders, SDD, and CLBP.</div></div><div><h3>Conclusions</h3><div>These findings support that the comorbidity among psychiatric disorders, SDD, and CLBP is due to the contribution of direct effects and shared biology linking these health outcomes. These pleiotropic mechanisms, together with sociocultural factors, play a key role in shaping the SDD-CLBP comorbidity patterns that have been observed across the psychopathology spectrum.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"5 6","pages":"Article 100588"},"PeriodicalIF":3.7000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Understanding the Comorbidities Among Psychiatric Disorders, Chronic Low Back Pain, and Spinal Degenerative Disease Using Observational and Genetically Informed Analyses\",\"authors\":\"Dan Qiu , Eleni Friligkou , Jun He , Brenda Cabrera-Mendoza , Mihaela Aslan , Mihir Gupta , Renato Polimanti\",\"doi\":\"10.1016/j.bpsgos.2025.100588\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Psychiatric disorders and symptoms are associated with differences in pain perception and sensitivity. These differences can have important implications in treating spinal degenerative disease (SDD) and chronic low back pain (CLBP).</div></div><div><h3>Methods</h3><div>Leveraging UK Biobank (UKB) (<em>n</em> = 402,072) and All of Us Research Program (AoU) (<em>n</em> = 157,415) data, we investigated the effects linking psychiatric disorders to SDD and CLBP. We applied multinominal regression models, polygenic risk scoring, and one-sample Mendelian randomization (MR) to triangulate the effects underlying the observed associations. We also performed gene ontology and drug-repurposing analyses to dissect the biology shared among mental illnesses, SDD, and CLBP.</div></div><div><h3>Results</h3><div>When we compared individuals affected only by SDD, those affected only by CLBP, and those affected by both conditions with control participants, observational and genetically informed analyses highlighted that the strongest effects across the 3 case groups were observed for alcohol use disorder, anxiety, depression, and posttraumatic stress disorder. Additionally, schizophrenia and its polygenic risk score appeared to have an inverse relationship with CLBP, SDD, and their comorbidity. One-sample MR highlighted a potential direct effect of internalizing disorders on the outcomes investigated that was particularly strong on SDD. Our drug repurposing analyses identified histone deacetylase inhibitors as targeting molecular pathways shared by psychiatric disorders, SDD, and CLBP.</div></div><div><h3>Conclusions</h3><div>These findings support that the comorbidity among psychiatric disorders, SDD, and CLBP is due to the contribution of direct effects and shared biology linking these health outcomes. These pleiotropic mechanisms, together with sociocultural factors, play a key role in shaping the SDD-CLBP comorbidity patterns that have been observed across the psychopathology spectrum.</div></div>\",\"PeriodicalId\":72373,\"journal\":{\"name\":\"Biological psychiatry global open science\",\"volume\":\"5 6\",\"pages\":\"Article 100588\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-08-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biological psychiatry global open science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667174325001429\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological psychiatry global open science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667174325001429","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
精神疾病和症状与疼痛感知和敏感性的差异有关。这些差异对治疗脊柱退行性疾病(SDD)和慢性腰痛(CLBP)具有重要意义。方法利用UK Biobank (n = 402,072)和All of Us Research Program (n = 157,415)的数据,研究精神障碍与SDD和CLBP之间的关系。我们应用多项回归模型、多基因风险评分和单样本孟德尔随机化(MR)来三角测量观察到的关联的影响。我们还进行了基因本体论和药物再利用分析,以剖析精神疾病、SDD和CLBP之间共有的生物学特征。结果:当我们将仅受SDD影响的个体、仅受CLBP影响的个体以及同时受两种情况影响的个体与对照组进行比较时,观察性和遗传学分析强调,在3个病例组中,酒精使用障碍、焦虑、抑郁和创伤后应激障碍的影响最大。此外,精神分裂症及其多基因风险评分似乎与CLBP、SDD及其合并症呈反比关系。单样本MR强调了内化障碍对所调查结果的潜在直接影响,尤其是对SDD的影响。我们的药物再利用分析确定了组蛋白去乙酰化酶抑制剂靶向精神疾病、SDD和CLBP共有的分子途径。结论:这些发现支持精神疾病、SDD和CLBP之间的共病是由于直接影响和共同的生物学关系导致的。这些多效性机制,连同社会文化因素,在形成在精神病理谱中观察到的SDD-CLBP共病模式中起着关键作用。
Understanding the Comorbidities Among Psychiatric Disorders, Chronic Low Back Pain, and Spinal Degenerative Disease Using Observational and Genetically Informed Analyses
Background
Psychiatric disorders and symptoms are associated with differences in pain perception and sensitivity. These differences can have important implications in treating spinal degenerative disease (SDD) and chronic low back pain (CLBP).
Methods
Leveraging UK Biobank (UKB) (n = 402,072) and All of Us Research Program (AoU) (n = 157,415) data, we investigated the effects linking psychiatric disorders to SDD and CLBP. We applied multinominal regression models, polygenic risk scoring, and one-sample Mendelian randomization (MR) to triangulate the effects underlying the observed associations. We also performed gene ontology and drug-repurposing analyses to dissect the biology shared among mental illnesses, SDD, and CLBP.
Results
When we compared individuals affected only by SDD, those affected only by CLBP, and those affected by both conditions with control participants, observational and genetically informed analyses highlighted that the strongest effects across the 3 case groups were observed for alcohol use disorder, anxiety, depression, and posttraumatic stress disorder. Additionally, schizophrenia and its polygenic risk score appeared to have an inverse relationship with CLBP, SDD, and their comorbidity. One-sample MR highlighted a potential direct effect of internalizing disorders on the outcomes investigated that was particularly strong on SDD. Our drug repurposing analyses identified histone deacetylase inhibitors as targeting molecular pathways shared by psychiatric disorders, SDD, and CLBP.
Conclusions
These findings support that the comorbidity among psychiatric disorders, SDD, and CLBP is due to the contribution of direct effects and shared biology linking these health outcomes. These pleiotropic mechanisms, together with sociocultural factors, play a key role in shaping the SDD-CLBP comorbidity patterns that have been observed across the psychopathology spectrum.